A CLINICAL PHARMACOLOGICAL APPROACH TO THE RATIONAL USE OF DRUGS IN DEPRESSIVE SYNDROME
Main Article Content
Abstract
A review of the literature on the neurobiological mechanisms of depressive disorders, which presents the role of biochemical changes in the cholinergic, serotonergic, dopaminergic and other neurohumoral systems in the development of depression. Modern approaches to the pharmacocorrection of depressive disorders are discussed in detail, and the question of the prospects of treating depression with anticholinergic drugs is also raised.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Aleksandrovsky Yu. A. Borderline mental disorders. - M.: 2010. - 496 p.
Ashmarin I.P., Stukalov P.V., Eshchenko N.D. Biochemistry of the brain: Uch. allowance. - St. Petersburg, 2019. - 328 p.
Borodin V.I., Kanaeva L.S., Mironova N.V., Zakharova K.V. Clinical efficacy and tolerability of the drug “Cipralex” (escitalopram) in the treatment of mild and moderately severe depression // Psychiatry and psychopharmacotherapy. — 2015 — T. 7, No. 5. — P. 3–6.
Vein A.M., Voznesenskaya T.G., Golubev V.L., Dyukova G.M. Depression in neurological practice. - M., 2012. - P. 30–44.
Vertogradova O. P. Depression (psychopathology, pathogenesis). - M., 2010.